Event: ESC Congress 2021 - The Digital Experience

Topic: Risk Factors and Prevention

Session: Great Debate: metformin – still first-line therapy in type 2 diabetes and heart disease?

Event: ESC Congress 2016

Topic: Diabetes management

Session: Addressing cardiovascular risk in type 2 diabetes - The LEADER trial